SMO and medulloblastoma: Based on these prior studies and the inverse correlation of MIF and CD74 in our tumor model, we propose that MIF functions in medulloblastoma to bias myeloid cells toward an Igf1+ phenotype, and acts more effectively in G-Smo tumors, which have higher Mif expression.